Lucid Diagnostics Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lucid Diagnostics Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Lucid Diagnostics Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $20.00K, a 566.67% increase year-over-year.
- Lucid Diagnostics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $2.00K.
- Lucid Diagnostics Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $2.00K.
- Lucid Diagnostics Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $17.00K, a 325.00% increase from fiscal 2024.
- Lucid Diagnostics Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $4.00K.
- Lucid Diagnostics Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $695.00K.
- Lucid Diagnostics Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $5.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | $24.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $20.00K 10-Q · filed 2026-05-13 | $35.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $17.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-12 | $16.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $11.00K 10-Q · filed 2026-08-12 | $14.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $3.00K 10-Q · filed 2026-05-13 | $3.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $4.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | |
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-13 | |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $695.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $6.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $502.00K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $187.00K 10-Q · filed 2023-05-15 | |
| 2020-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $5.00K 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |